These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31035285)

  • 1. The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
    Chait A; Eckel RH
    Ann Intern Med; 2019 May; 170(9):626-634. PubMed ID: 31035285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chylomicronemia syndrome].
    Francis A; Levy Y
    Harefuah; 2002 Feb; 141(2):201-3, 221, 220. PubMed ID: 11905095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
    Falko JM
    Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifactorial chylomicronemia syndrome.
    Chait A
    Curr Opin Endocrinol Diabetes Obes; 2024 Apr; 31(2):78-83. PubMed ID: 37994661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chylomicronemia and the chylomicronemia syndrome: a practical approach to management.
    Leaf DA
    Am J Med; 2008 Jan; 121(1):10-2. PubMed ID: 18187065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia.
    Brunzell JD; Bierman EL
    Med Clin North Am; 1982 Mar; 66(2):455-68. PubMed ID: 7040847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene.
    Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ
    BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology and emerging treatments for familial chylomicronemia syndrome.
    Spagnuolo CM; Hegele RA
    Expert Rev Endocrinol Metab; 2024 Jul; 19(4):299-306. PubMed ID: 38866702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of primary chylomicronemia due to familial hypertriglyceridemia by omega-3 fatty acids.
    Richter WO; Jacob BG; Ritter MM; Schwandt P
    Metabolism; 1992 Oct; 41(10):1100-5. PubMed ID: 1406295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe hypertriglyceridemia : Diagnostics and new treatment principles].
    Kassner U; Dippel M; Steinhagen-Thiessen E
    Internist (Berl); 2017 Aug; 58(8):866-876. PubMed ID: 28516251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical outcomes and management of hypertriglyceridemia in children with Apo-CII deficiency.
    Yoldas Celik M; Canda E; Yazici H; Erdem F; Yuksel Yanbolu A; Atik Altinok Y; Pariltay E; Akin H; Kalkan Ucar S; Coker M
    Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1798-1806. PubMed ID: 38503616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.
    Beigneux AP; Franssen R; Bensadoun A; Gin P; Melford K; Peter J; Walzem RL; Weinstein MM; Davies BS; Kuivenhoven JA; Kastelein JJ; Fong LG; Dallinga-Thie GM; Young SG
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):956-62. PubMed ID: 19304573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial chylomicronemia in a nine months old infant.
    Lone SW; Imdad A; Billoo AG
    J Coll Physicians Surg Pak; 2008 Oct; 18(10):655-6. PubMed ID: 18940129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".
    Moulin P; Dufour R; Averna M; Arca M; Cefalù AB; Noto D; D'Erasmo L; Di Costanzo A; Marçais C; Alvarez-Sala Walther LA; Banach M; Borén J; Cramb R; Gouni-Berthold I; Hughes E; Johnson C; Pintó X; Reiner Ž; van Lennep JR; Soran H; Stefanutti C; Stroes E; Bruckert E
    Atherosclerosis; 2018 Aug; 275():265-272. PubMed ID: 29980054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
    Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D
    J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1.
    Ahmad Z; Wilson DP
    J Clin Lipidol; 2014; 8(6):635-639. PubMed ID: 25499947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency.
    Xia Y; Zheng W; Du T; Gong Z; Liang L; Wang R; Yang Y; Zhang K; Lu D; Chen X; Sun Y; Sun Y; Xiao B; Qiu W
    J Clin Lipidol; 2023; 17(6):808-817. PubMed ID: 37858495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic algorithm for familial chylomicronemia syndrome.
    Stroes E; Moulin P; Parhofer KG; Rebours V; Löhr JM; Averna M
    Atheroscler Suppl; 2017 Jan; 23():1-7. PubMed ID: 27998715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial chylomicronemia syndrome.
    Sugandhan S; Khandpur S; Sharma VK
    Pediatr Dermatol; 2007; 24(3):323-5. PubMed ID: 17542893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
    Chaudhry R; Viljoen A; Wierzbicki AS
    Expert Rev Clin Pharmacol; 2018 Jun; 11(6):589-598. PubMed ID: 29842811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.